HUMAN ATRIAL FIBRILLATION--CHANGES IN CHANNEL EXPRESSION

人类心房颤动——通道表达的变化

基本信息

  • 批准号:
    2735352
  • 负责人:
  • 金额:
    $ 14.49万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-07-01 至 2000-06-30
  • 项目状态:
    已结题

项目摘要

One million Americans suffer from atrial fibrillation, the most common chronic arrhythmia. Atrial fibrillation is responsible for significant discomfort, morbidity and mortality. The mechanisms involved in the perpetuation of atrial fibrillation are thought to include a shortening of the effective refractory period of the atrium, but the details of the electrophysiological remodeling which the atria undergoes are poorly understood. We propose to use a novel, highly integrated approach to explore the relationship between the electrophysiological properties of the intact, isolated atrial tissue, the distribution of K+ and Ca2+ currents in isolated myocytes, and the expression of specific K+ and ca2+ channel subunits in the membrane fractions of the same atrial tissue. The specific aims of the proposal are: 1)To evaluate the rate-dependent modulation of atrial wavelength (action potential duration, refractory period, and conduction velocity) in atrial tissue obtained from patients in normal sinus rhythm or in chronic atrial fibrillation. 2) To characterize the action potentials, the density of specific K+ components, and the density of voltage-gated Ca2+ current in myocytes isolated from the same atrial tissue used in - aim #1. 3)To determine the density and relative distribution of the K+ and CA2+ channel alpha subunits responsible for the functional currents measured in the same atrial tissue and myocytes used in aims #1 and #2. 4)To correlate the biochemical measurements (aim #3) with the electrophysiological measurements (aims #1 and #2), and with clinical measures of refractoriness obtained during surgical procedures. Microelectrode, bipolar and optical measurements of electrical activity in isolated human atrial tissue, perforated-patch whole cell recording of K+ and Ca2+ currents in individual atrial myocytes, and Western blot analysis of K+ and Ca2+ channel (x-subunits expression in atrial tissue and myocytes will be used to accomplish the experimental aims. The proposed experiments will provide novel and fundamental information on the impact of chronic atrial fibrillation on ion channel expression in the human atrium. This information is needed to identify novel, safer and more effective strategies for the treatment of this disabling arrhythmia, by identifying logical, specific molecular targets for future therapeutic interventions.
100万美国人患有心房颤动, 常见的慢性心律失常心房颤动是导致 显著不适、发病率和死亡率。的机制 心房颤动的持续存在被认为 包括有效不应期的缩短, 心房,但电生理重构的细节 心房所经历的变化还知之甚少我们建议使用 一种新颖的、高度综合的方法来探索 完整的、分离的、 离体心房肌细胞钾电流和钙电流的分布 心肌细胞特异性钾通道和钙通道的表达 在同一心房组织的膜部分的亚基。的 该建议的具体目标是:1)评估利率依赖 心房波长的调制(动作电位持续时间, 不应期和传导速度 从正常窦性心律或慢性心房颤动患者中获得 纤维性颤动2)为了表征动作电位, 特定K+成分的含量以及电压门控Ca 2+的密度 从相同的心房组织中分离的肌细胞中的电流, 目标#1。3)确定土壤的密度和相对分布, K+和CA 2+通道α亚单位负责功能性 在相同的心房组织和肌细胞中测量的电流, 目标#1和#2。4)将生物化学测量值(目的)关联起来, #3)电生理测量(目标#1和#2), 并与临床测量期间获得的不应性 外科手术微电极,双极和光学 离体人心房肌电活动的测量 K+和Ca 2+的组织穿孔膜片全细胞记录 单个心房肌细胞中的电流,以及Western印迹分析 K+和Ca 2+通道(心房组织中的x-亚基表达, 将使用肌细胞来实现实验目的。 的 拟议的实验将提供新的和基本的信息, 慢性心房颤动对离子通道的影响 在人类心房中的表达。需要这些信息, 确定新的、更安全和更有效的战略, 治疗这种致残性心律失常,通过识别逻辑, 未来治疗干预的特定分子靶点。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David R Van Wagoner其他文献

David R Van Wagoner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David R Van Wagoner', 18)}}的其他基金

Engineered Heart Tissue and Atrial Phenotyping Scientific Core 1
工程心脏组织和心房表型科学核心 1
  • 批准号:
    10410645
  • 财政年份:
    2022
  • 资助金额:
    $ 14.49万
  • 项目类别:
Engineered Heart Tissue and Atrial Phenotyping Scientific Core 1
工程心脏组织和心房表型科学核心 1
  • 批准号:
    10646343
  • 财政年份:
    2022
  • 资助金额:
    $ 14.49万
  • 项目类别:
Genes and Metabolism: Targeting Mitochondrial Dysfunction in Atrial Fibrillation
基因与代谢:针对心房颤动中的线粒体功能障碍
  • 批准号:
    10410649
  • 财政年份:
    2022
  • 资助金额:
    $ 14.49万
  • 项目类别:
Genes and Metabolism: Targeting Mitochondrial Dysfunction in Atrial Fibrillation
基因与代谢:针对心房颤动中的线粒体功能障碍
  • 批准号:
    10646366
  • 财政年份:
    2022
  • 资助金额:
    $ 14.49万
  • 项目类别:
Oxidative Stress and Atrial Fibrillation
氧化应激和心房颤动
  • 批准号:
    6743718
  • 财政年份:
    2001
  • 资助金额:
    $ 14.49万
  • 项目类别:
Oxidative Stress and Atrial Fibrillation
氧化应激和心房颤动
  • 批准号:
    6330682
  • 财政年份:
    2001
  • 资助金额:
    $ 14.49万
  • 项目类别:
Oxidative Stress and Atrial Fibrillation
氧化应激和心房颤动
  • 批准号:
    6537860
  • 财政年份:
    2001
  • 资助金额:
    $ 14.49万
  • 项目类别:
Oxidative Stress and Atrial Fibrillation
氧化应激和心房颤动
  • 批准号:
    6638682
  • 财政年份:
    2001
  • 资助金额:
    $ 14.49万
  • 项目类别:
HUMAN ATRIAL FIBRILLATION--CHANGES IN CHANNEL EXPRESSION
人类心房颤动——通道表达的变化
  • 批准号:
    6030784
  • 财政年份:
    1997
  • 资助金额:
    $ 14.49万
  • 项目类别:
HUMAN ATRIAL FIBRILLATION--CHANGES IN CHANNEL EXPRESSION
人类心房颤动——通道表达的变化
  • 批准号:
    2398227
  • 财政年份:
    1997
  • 资助金额:
    $ 14.49万
  • 项目类别:

相似海外基金

Sustainable wearable e-textiles for remote monitoring of atrial fibrillation patients
用于远程监测心房颤动患者的可持续可穿戴电子纺织品
  • 批准号:
    EP/Y021096/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.49万
  • 项目类别:
    Research Grant
TARGET: Health virtual twins for the personalised management of stroke related to atrial fibrillation
目标:健康虚拟双胞胎,用于房颤相关中风的个性化管理
  • 批准号:
    10114601
  • 财政年份:
    2024
  • 资助金额:
    $ 14.49万
  • 项目类别:
    EU-Funded
Health virtual twins for the personalised management of stroke related to atrial fibrillation
健康虚拟双胞胎用于房颤相关中风的个性化管理
  • 批准号:
    10102834
  • 财政年份:
    2024
  • 资助金额:
    $ 14.49万
  • 项目类别:
    EU-Funded
TARGET: Health virtual twins for the personalised management of stroke related to atrial fibrillation
目标:健康虚拟双胞胎,用于房颤相关中风的个性化管理
  • 批准号:
    10104001
  • 财政年份:
    2024
  • 资助金额:
    $ 14.49万
  • 项目类别:
    EU-Funded
Identifying novel & repurposing drug targets for Atrial Fibrillation MEDicines
识别小说
  • 批准号:
    EP/Z000211/1
  • 财政年份:
    2024
  • 资助金额:
    $ 14.49万
  • 项目类别:
    Research Grant
I-Corps: Wearable Magnetoelastic Generator for Atrial Fibrillation
I-Corps:用于心房颤动的可穿戴磁弹发生器
  • 批准号:
    2324601
  • 财政年份:
    2023
  • 资助金额:
    $ 14.49万
  • 项目类别:
    Standard Grant
Association between atrial fibrillation and cognitive decline
心房颤动与认知能力下降之间的关联
  • 批准号:
    23K15136
  • 财政年份:
    2023
  • 资助金额:
    $ 14.49万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Clarifying Pathophysiology of Atrial Fibrillation by Tissue Multi-Omics Analysis of Atrial Myocardium
通过心房心肌的组织多组学分析阐明心房颤动的病理生理学
  • 批准号:
    23KJ0378
  • 财政年份:
    2023
  • 资助金额:
    $ 14.49万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Storytelling for Reducing Gap in AC Use in African Americans with Atrial Fibrillation
讲故事以减少患有心房颤动的非洲裔美国人使用交流电的差距
  • 批准号:
    10667019
  • 财政年份:
    2023
  • 资助金额:
    $ 14.49万
  • 项目类别:
Differences in Women and Men with Atrial Fibrillation
女性和男性房颤患者的差异
  • 批准号:
    10822952
  • 财政年份:
    2023
  • 资助金额:
    $ 14.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了